Skip Maine state header navigation

Agencies | Online Services | Help

Skip All Navigation

Maine.gov > PFR Home > Insurance Regulation > Hearing Decision Index > Document 438 : INS 99-14 : Hearing Decision

STATE OF MAINE
DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
BUREAU OF INSURANCE

 

IN RE: APPLICATION OF ASSOCIATED HOSPITAL SERVICE OF MAINE, d/b/a BLUE CROSS AND BLUE SHIELD OF MAINE, TO CONVERT TO A STOCK INSURER AND VOLUNTARILY LIQUIDATE AND DISSOLVE )
)
)
)
)
)
)
)
IN RE: APPLICATION OF ANTHEM HEALTH PLAN OF MAINE, INC.,
TO ACQUIRE THE ASSETS OF ASSOCIATED HOSPITAL SERVICE OF MAINE, d/b/a BLUE CROSS AND BLUE SHIELD OF MAINE, AND RELATED TRANSACTIONS

Docket NO. INS 99-14 (CONSOLIDATED)

)
)
)
)
)
)
)
)
)
)
)
ANTHEM INSURANCE COMPANIES, INC.’S STATEMENT IN OPPOSITION TO CONSUMER INTERVENORS’ MOTION TO COMPEL

 

 

February 23, 2000

 

INTRODUCTION

In its Memorandum in Support of Objections to the Consumer Intervenors, dated February 14, 2000 ("Memo"), Anthem detailed the chronology of this proceeding, including the voluminous discovery already produced by the Applicants, and its objections to providing all of the information responsive to the late and overly burdensome requests served by the intervenors. To avoid repetition, Anthem incorporates the Memo, and in particular the section entitled "General Objections to the Scope and Breadth of the Request", by reference.

Although Anthem objected to the Consumer Intervenors’ First Discovery Request (the "Request"), Anthem provided substantial written and documentary responses in an effort to give the Consumer Intervenors meaningful responses. Notwithstanding Anthem’s substantive response, the Consumer Intervenors have now moved to compel Anthem to provide additional information.

The Applicants have already responded to over 300 multi-part discovery requests and submitted responsive documents that would fill more than 6 banker boxes. For the reasons set forth below, and in the Memo, Anthem objects to having to answer still more discovery responses this late in the proceeding and at a time when the Company’s focus should be turned toward preparation of prefiled testimony and the April hearing.

Each of the disputed requests is discussed in turn.

 

DISCUSSION

  1. Please provide all documents prepared by or for the applicants related to purchasing any interest in Harvard Pilgrim Community Health Plans. Please describe in detail any and all discussions and/or communications by Anthem with Harvard Pilgrim Community Health Plans or its representatives and/or with any governmental agency having jurisdiction over Harvard Pilgrim Community Health Plans.

    Anthem’s Response to Consumers’ Argument:

     

    In its Memo, Anthem responded that, in the absence of any agreement between Anthem and Harvard Pilgrim, the request is irrelevant. That remains the case. All of the Consumer Intervenors’ arguments on the relevance of the request rely on the underlying assumption that there is actually an agreement in place for Anthem to purchase Harvard Pilgrim. Because there is no such agreement, the Consumer Intervenors’ arguments are without merit.
  2. Please provide all documents prepared by or for Anthem related to the preparation of the attached Anthem policyholder notice in Kentucky (see Attachment "A").

    Anthem’s Response to Consumers’ Argument:

     

     

     

    In its Memo, Anthem explained why the transaction in Kentucky, and the policyholder notice, are irrelevant to this transaction. The 1993 transaction in Kentucky transaction involved a merger where no "cash" was to be paid. Also, the dispute surrounding the funding of the trust foundation in Kentucky arose in the absence of a clear statutory guidance as to the effects of the transaction. In the Kentucky merger, allocation of funds to a trust would have reduced reserves, and Anthem so notified its policyholders. By contrast, the present transaction is an acquisition with a specific dollar amount being paid for the BCBSME assets and a specific statutory mechanism for allocating the proceeds. In other words, unlike in Kentucky, the net purchase price will go to the trust fund and that will not reduce the Maine BCBS reserves. Just as the Kentucky policyholder notice is irrelevant, so too are "all documents prepared by or for Anthem" that are related to that notice.
  3. Please provide a chart that describes in detail all Anthem purchases of BCBS plans anywhere in the United States from 1993 to date and provide a schedule of premiums for each and every product offered by the seller during the 24 month period prior to the sale and by Anthem in the 24 month period subsequent to the sale. In states where Anthem has less than one year of premium experience, such as New Hampshire and Colorado/Nevada, please state the premiums currently in place and the premiums that Anthem has sought or will seek in the next six months for each and every product offered.

    Anthem’s Response to Consumers’ Argument:

     

     

     

    Anthem does not have any duty to generate new analyses or obtain information from other sources in order to respond to discovery requests from intervenors. In its Memo, Anthem reported that it does not have pre-transaction premium information in many cases and it has no duty to research back to 1991 (i.e., 24 months prior to the Kentucky merger) to learn the premium that was charged "for each and every product offered" by the pre-merger companies, and then investigate what Anthem charged in premium during the subsequent 24 months "for each and every product." Premium levels are driven by factors specific to particular markets, including policy provisions and coverage; costs of services rendered by providers; competition; and reserve requirements. Accordingly, even if Anthem had the requested information readily available, in order to make a meaningful comparison, the Superintendent would have to see evidence reflecting the premiums charged by all of Anthem’s competitors in each state for the relevant periods as well (i.e., were any premium increases post-transaction out of line with premium increases for other competitors in the specific region?). In addition, analysis of the factors affecting rates in each market would be necessary for any meaningful analysis of rates. Comparison without the market data for each region at the applicable time would be meaningless. But even if Anthem’s singular data would have marginal relevance, it is outweighed by Anthem’s burden if it is forced to perform the investigation necessary to respond to the request.
  4. For each purchase identified in response to question number 13, please provide a chart that describes in detail each and every: a) product added and/or dropped; b) increase or decrease in coinsurance rates and/or copayment amounts by item or service and by product; c) increase or decrease in lifetime and/or annual benefit amounts or payments by product; and d) increase or decrease in benefits and/or coverage levels by item or service and by product, for the first 24 months after the purchase. In states where Anthem has less than one year of experience, such as New Hampshire and Colorado/Nevada, please provide the above information as it is currently in effect and any proposed modifications Anthem has sought or will seek in the next six months for each and every product offered.

    Anthem’s Response to Consumers’ Argument:

     

     

     

    For the same reasons articulated in response to question no. 13, this request is irrelevant and unreasonably burdensome. This request goes even further, however, requiring Anthem to create a "chart" that provides detailed information on all product changes, changes in coinsurance rates, benefit amounts, and benefit coverage levels for the first 24 months after the applicable transaction with Anthem. The Consumer Intervenors say they want this information to "determin[e] what would happen to any other Plan that Anthem takes over." Any proper inquiry would be limited to what plans Anthem has for Anthem Health Plans of Maine, Inc., i.e., the subsidiary to be formed in Maine if the present transaction is approved. However, the question goes far beyond that. Moreover, Anthem has already provided substantial information concerning its plans for Anthem Health Plans of Maine, Inc. Most importantly, the proposed purchase contemplates bulk reinsurance of all of BCBSME’s current health insurance products and Anthem’s assumption of all of BCBSME’s provider agreements. Anything beyond the responses already provided is irrelevant and certainly complying with this broad request is overly burdensome, particularly in light of the tangential nature of the information sought.
  1. Please provide all documents prepared by or for Anthem related to demutualization from 1995 to date.

    Anthem’s Response to Consumers’ Argument:

     

     

    In its Memo, Anthem stated that, from time to time, it has analyzed whether Anthem’s corporate missions and goals are best achieved as a mutual company. To date, Anthem continues to be a mutual company. The Consumer Intervenors argue that "[a]ny plans to demutualize would have a direct and substantial affect on Maine policyholders under Anthem ownership in terms of price and coverage policies." How? If the proposed transaction is approved, the subsidiary to be formed, Anthem Health Plans of Maine, d/b/a Anthem BCBS, will be a for profit stock company, not a mutual insurer. In any event, information regarding demutualization, beyond that provided in the Memo, is irrelevant.
  2. Please provide all documents prepared by or for Anthem Insurance Companies, Inc. of Indiana related to the positive or negative effects a demutualization of Anthem Insurance Companies, Inc. of Indiana would have on insureds in Maine and any other state in which Anthem operates. Please describe in detail what persons would receive stock, dividends, assets, or anything of value and in what proportions if Anthem Insurance Companies, Inc. of Indiana were to demutualize under current Indiana law. Please provide all documents prepared by or for Anthem Insurance Companies, Inc. of Indiana related to lobbying efforts by Anthem Insurance Companies, Inc. of Indiana in connection with the passage of Senate Bill 33, affecting Indiana Code sections 27-9-1, et seq.

    Anthem’s Response to Consumers’ Argument:

    Please see Anthem’s response to question no. 18.
  1. Please provide a chart that describes in detail the medical underwriting practices and/or criteria used by the applicants by product and by item or service. Please include in the chart all waiting periods, exclusions of services and items, exclusionary periods, rate and rating variations which are dependent on age, sex, health status and medical condition, used or in effect for each of the calendar years 1997, 1998, 1999 and 2000.

    Anthem’s Response to Consumers’ Argument:

     

     

    Researching and preparing a new "chart" that includes 4 years worth of data "by product and by item or service" that includes all of the items enumerated in the request is unreasonable and Anthem has no duty to do so in response to an intervenor’s discovery request. Moreover, Anthem provided a fairly lengthy narrative response to this question, pointing out that its underwriting practices are confined, in large part, to the regulations of the applicable state. The burden of attempting to comply with the Consumer Intervenors’ request is far outweighed by the relevance of the response.
  1. In which state(s) does Anthem impose or anticipate imposing waiting or exclusionary periods for prescription drugs, durable medical equipment or supplies, and mental health services? Please provide all documents related to the waiting or exclusionary period(s) for each of these items and services.

    Anthem’s Response to Consumers’ Argument:

     

     

    The Consumer Intervenors argue that Anthem’s response to this request is incomplete in two ways: (1) that the response does not include durable medical equipment, and (2) Anthem did not include a copy of the referenced certificate rider.

    First, Anthem’s response does include information concerning waiting periods for durable medical equipment: "Anthem’s certificate rider for any new FDA-approved drug product or technology, including, but not limited to, medications, medical supplies, and/or devices . . . is excluded from coverage for the first six months after the date the product or technology received FDA new drug approval or other applicable FDA approval."

    Second, Anthem will provide a copy of the certificate rider as a supplement to the initial response.

  1. Please provide a list with the names, addresses and phone numbers of the independent review organizations (IROs) with which Anthem and BCBSME have contracted and/or intend to contract during the calendar years 1998, 1999, and 2000. Please provide the total number of appeals made to each of these IROs during the calendar years 1998 and 1999. How many appeals were denied in each of those years? Provide a redacted copy of a decision by each of the identified IROs for each of the calendar years 1998 and 1999.

    Anthem’s Response to Consumers’ Argument:

     

     

     

    Although irrelevant on its face, in response to this question, Anthem provided a narrative and the names and addresses of the IROs with whom it contracts. Anthem has already submitted information concerning customer complaints, as well as its complaint ratios for the states in which it operates. The burden of compiling the requested information for multiple years and in multiple jurisdictions is outweighed by the minimal probative value of the information sought. In light of the information already supplied, the Consumer Intervenors’ request to review a redacted copy of an IRO decision is unreasonable in that review of one decision in isolation would be meaningless.
  2. Provide all documents prepared by or for Anthem and BCBSME which define or provide definitions of the terms "medical necessity", "medically necessary", "short term therapy", "case management", "experimental treatment", "clinical trial" and "emergency" in effect during the calendar year 1999 for each state in which Anthem operates.

    Anthem’s Response to Consumers’ Argument:

    In its Memo, Anthem explained that, because Anthem is assuming the BCBSME policies, any relevant definitions of the above terms would relate to those contracts. "All documents prepared by or for Anthem" that define those terms "for each state in which Anthem operates" are irrelevant. As Anthem has grown through Blue Cross and Blue Shield mergers and acquisitions, it has assumed contracts of insurance that contain definitions for the above terms that are substantially similar, but nonetheless not uniform. To date, the company has not taken any steps to bring uniformity to these definitions on a company-wide basis. Thus, even if the definitions in other states were marginally relevant, which they are not given the bulk reinsurance agreement, the probative value is significantly outweighed by the burden on Anthem if it is forced to produce all documents that contain definitions for any of those terms and for all states.
  1. Please provide all documents prepared by or for the applicants related to criteria used or in effect for the purpose of determining whether someone qualifies and/or continues to qualify for case management services for each of the calendar years 1998 and 1999. Please provide the aggregate number of case management services requested and the aggregate number of case management services denied by the applicants during those two years. How many of those denials were appealed to the applicants? How many were reversed on appeal by the applicants? Please provide one redacted copy of an Anthem decision and one redacted copy of a BCBSME decision denying case management services for each of the calendars years 1998 and 1999.

    Anthem’s Response to Consumers’ Argument:

     

     

    In response to this request, Anthem submitted a lengthy narrative describing the diagnoses and services that would trigger case management, as well as documents reflecting Anthem BCBS of Connecticut’s trigger list. The Consumer Intervenors argue that Anthem "provided no documents that provide the criteria for determining whether someone qualifies for case management services if they have one of the diagnoses." As stated in the response, case management is offered if a member is diagnosed with one of the illnesses, or requires one of the services, outlined in the trigger lists provided in the response.

 

DATED: February 23, 2000

_____________________________

James B. Zimpritch, Esq.

Jeffrey M. White, Esq.

Catherine R. Connors, Esq.

PIERCE ATWOOD

One Monument Square

Portland, Maine 04101

(207) 791-1100

Attorneys for Anthem Insurance Companies, Inc

 

CERTIFICATE OF SERVICE

The undersigned hereby certifies that on February 23, 2000 a copy of Anthem Insurance Companies, Inc.’s Statement in Opposition to the Consumer Intervenors’ Motion to Compel was served by email, United States mail, first class postage prepaid, or, where indicated, by hand delivery, on each of the persons listed below.

Robert S. Frank, Esq.

Harvey & Frank

Two City Center

P.O. Box 126

Portland, Maine 04112

e-mail: frank@harveyfrank.com

 

(Blue Cross/Blue Shield of Maine)

Judith Chamberlain, Esq.

State of Maine

Department of the Attorney General

6 State House Station

Augusta, Maine 04333-0006

e-mail: judy.chamberlain@state.me.us

 

(Bureau of Insurance)

William H. Laubenstein, Esq.

State of Maine

Department of the Attorney General

6 State House Station

Augusta, Maine 04333-0006

e-mail: bill.laubenstein@state.me.us

 

(Office of the Attorney General)

Gregory A. Brodek, Esq.

Duane, Morris & Heckscher, LLP

15 Columbia Street, 4th Floor

Bangor, Maine 04401-6355

e-mail: gabrodek@duanemorris.com

 

(Maine Health Alliance)

Joseph P. Ditre, Esq.

Consumer Health Law Program

One Weston Court, Level One

P.O. Box 2490

Augusta, Maine 04338-2490

e-mail: jditre@mainecahc.org

 

(Consumers for Affordable Health Care Foundation/Coalition)

Michele M. Garvin, Esq.

Ropes & Gray

One International Place

Boston, Massachusetts 02110-2624

e-mail: Mgarvin@Ropesgray.com

 

(Central Maine Healthcare Corporation; Central Maine Partners Health Plan)

Robert I. Goldman

Maine Council of Senior Citizens

27 Bowery Beach Road

Cape Elizabeth, Maine 04107

e-mail: Rgoldma1@maine.rr.com

 

(Maine Council of Senior Citizens)

Bonnie Post

Executive Director of the Maine Ambulatory Care Coalition

P.O. Box 390

Manchester, Maine 04351

e-mail: bdpmacc@mint.net

 

(Sacopee Valley Health Center, Regional Medical Center at Lubec, Eastport Health Care, Inc., and the Maine Ambulatory Care Coalition)

John Dieffenbacher-Krall

Executive Director

Maine People’s Alliance

192 State Street

Portland, Maine 04101

e-mail: MPA@gwi.net

 

(Maine People’s Alliance)

Gordon H. Smith, Esq.

Maine Medical Association

30 Association Drive

P.O. Box 190

Manchester, Maine 04351

e-mail: gsmith@ctel.net

 

(Thomas D. Hayward, M.D.,

Maroulla S. Gleaton, M.D.,

And the Maine Medical Association)

 

Donald E. Quigley, Esq.

General Counsel

465 Congress Street, Suite 600

Portland, Maine 04101-3537

e-mail: quigld@mail.mmc.org

 

(Maine Medical Center)

Sandra L. Parker, Esq.

Attorney for MHA, Inc.

150 Capitol Street

Augusta, Maine 04330

e-mail: sparker@themha.org

 

(MHA, Inc.)

 

Kellie P. Miller, M.S.

Executive Director

Maine Osteopathic Association

693 Western Avenue

Manchester, Maine 04351

e-mail: meosteo@mint.net

 

(Maine Osteopathic Association)

Edward Miller

Executive Director

American Lung Association of Maine

122 State Street

Augusta, Maine 04330

e-mail: emiller@mainelung.org

 

(American Lung Association of Maine)

 

DATED: February 23, 2000

_____________________________

James B. Zimpritch, Esq.

Jeffrey M. White, Esq.

Catherine R. Connors, Esq.

PIERCE ATWOOD

One Monument Square

Portland, Maine 04101

(207) 791-1100

Attorneys for Anthem Insurance Companies, Inc.

Last Updated: August 22, 2012